Latest for Pulmonary Alveolar Proteinosis
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Pulmonary Alveolar Proteinosis
In autoimmune PAP, the immune system makes antibodies that bind to GM-CSF and block it. The macrophages fall silent, surfactant piles up, and the air sacs slowly fill with a sludge that keeps air from getting in and oxygen from crossing into the blood. The same loss of GM-CSF weakens the macrophages' ability to fight germs, so lung infections are more common.
Keep reading about Pulmonary Alveolar Proteinosis
On a CT scan the lungs show a pattern doctors call crazy paving: patches of haze crossed by fine lines. That pattern raises suspicion but does not prove PAP, and a bronchoscopy can confirm surfactant buildup without saying which type of PAP it is. The test that settles the autoimmune form is a blood test for the GM-CSF autoantibody, which the PAP Foundation describes as 100% sensitive and specific.
Savara, the company developing molgramostim, runs a program called aPAP ClearPath through which doctors can order the blood test for eligible patients at no charge to the patient, the doctor or insurers. No one knows what sets the autoimmune process off, and about 5-7% of people improve on their own.
For people who need treatment, the standard is whole lung lavage. Under general anesthesia, one lung is kept breathing on a ventilator while the other is washed with saline to flush the surfactant out. Some people need it once, others every year or so, and a few need it monthly. NORD says most people with autoimmune PAP respond very well to it. Each session is done under general anesthesia that often lasts 3 to 6 hours, and the PAP Foundation describes days in the hospital and 1 to 2 weeks of recovery pain after each one.
What are the symptoms of Pulmonary Alveolar Proteinosis?
These are common symptoms of Pulmonary Alveolar Proteinosis, and how strong they are varies from person to person.
- Shortness of breath that creeps in slowly, first with activity and later at rest
- A cough that is dry or brings up whitish phlegm
- Tiredness and a reduced ability to exercise, such as being winded on a flight of stairs
- Bluish fingertips from low blood oxygen as the disease progresses
- Fever, chest pain or blood-streaked phlegm, usually a sign of a lung infection on top of PAP
- No symptoms at all in about 3 in 10 people at any given time, with the disease sometimes found by accident
Who gets Pulmonary Alveolar Proteinosis?
Autoimmune PAP most often appears in adults between 30 and 40, though it has been diagnosed in children as young as 3. It is more common in men, and smokers are affected more often, which suggests cigarette smoke can act as a trigger. The hereditary form, caused by changes in the genes for the GM-CSF receptor, usually shows up in children under 10. Because the symptoms resemble asthma or pneumonia, the PAP Foundation says it is often misdiagnosed at first, and Savara says an accurate diagnosis is delayed by 18 months on average.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Which new Pulmonary Alveolar Proteinosis medicines are in trials?
Investigational medicines Trial Friend tracks for Pulmonary Alveolar Proteinosis, with trial results, safety findings and where each one stands.
How to get help paying for Pulmonary Alveolar Proteinosis treatment
Charity funds and drugmaker programs for Pulmonary Alveolar Proteinosis, checked at the source.
- From a charity · NORD RareCareAutoimmune Pulmonary Alveolar Proteinosis (aPAP) Medical Assistance fundOpen
Pays for: Medical and medication costs.
The foundation says: “Accepting new applications and re-enrollments for next year”
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
How Pulmonary Alveolar Proteinosis is diagnosed
The common autoimmune form is not inherited. A rare hereditary form in children is caused by changes in the genes for the GM-CSF receptor and is diagnosed by genetic testing.
Trusted Pulmonary Alveolar Proteinosis resources
Reputable organizations and medical references for learning more about Pulmonary Alveolar Proteinosis, including disease registries, foundation resources, and clinical guidelines.
- National Organization for Rare Disorders (NORD) - Pulmonary Alveolar Proteinosis
- PAP Foundation - Frequently Asked Questions
- PAP Foundation - 2024 Coverage Letter of Support
- Trapnell et al., N Engl J Med 2025 - Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA-2)
- Savara - Second Quarter 2026 Financial Results and Business Update (PDUFA date November 22, 2026)
- Savara - Diagnosing Autoimmune PAP (aPAP ClearPath Testing Program)
- PAP Foundation - PAP Clinical Centers